GLP-1 side effects boost mint sales
The guest argued that the rise of GLP-1 weight loss drugs like Ozempic is driving a surprising surge in demand for mints and gum due to a side effect known as 'Ozempic breath.'
The argument
The discussion highlighted that Hershey's CEO reported an 8% increase in sales for their Ice Breakers mints and gum in Q1 2026, directly attributing the growth to GLP-1 users managing this side effect.
The thesis, stress-tested
✓ What validates it
- ✓Continued outsized growth in Hershey's mint and gum division in upcoming quarterly reports
- ✓Competitors in the confectionary space reporting similar GLP-1-driven sales lifts
▸ Risks discussed
- ▸Consumer habits could shift away from mints to other breath-freshening alternatives
- ▸New formulations of GLP-1 drugs might eliminate the bad breath side effect
AFFILIATE LINK · ZORTIX MAY EARN A COMMISSION · NEVER A RECOMMENDATION TO TRADE